骨髓免疫细胞和药物耐药性在急性髓性白血病
Miao Zhang1,2, You Yang1,2, Jing Liu1,2
1Department of Pediatrics (Hematological Oncology), Children Hematological Oncology and Birth Defects Laboratory, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, China.
Experimental biology and medicine (Maywood, N.J.)
|February 26, 2025
概括
骨髓是指骨髓中的骨髓.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 血液学 血液学 血液学
背景情况:
- 骨髓微环境在急性髓性白血病 (AML) 发病过程中起着至关重要的作用.
- 骨髓内的免疫细胞功能障碍有助于AML的治疗抵抗.
- 了解骨髓和白血病之间的相互作用是有效治疗的关键.
研究的目的:
- 审查骨髓微环境中免疫细胞的当前研究,以及它们与AML中的化学抵抗的联系.
- 探索免疫抑制细胞和耗尽的效应细胞如何促进AML的免疫逃脱.
- 为开发针对AML的免疫疗法提供新的见解.
主要方法:
- 关于骨髓免疫细胞和AML化学抵抗的最新研究的文献综述.
- 对调控性T细胞 (Tregs),髓质衍生抑制细胞 (MDSCs),细胞毒性T淋巴细胞 (CTLs),树突细胞 (DCs) 和自然杀手细胞 (NK) 的作用进行分析.
- 检查免疫逃生机制及其与治疗耐药性的联系.
主要成果:
- 免疫抑制细胞 (Tregs,MDSCs) 的异常数量和功能促进白血病免疫逃生.
- 效应细胞 (CTL,DC,NK) 的功能障碍和耗尽进一步导致治疗耐药性.
- 骨髓的免疫抑制位是AML治疗失败的重要因素.
结论:
- 骨髓免疫微环境在AML化学抵抗中起着至关重要的作用.
- 准骨髓中的免疫细胞为AML免疫疗法提供了有前途的途径.
- 对这些细胞相互作用的进一步研究可以改善AML的治疗策略.
更多相关视频
06:28Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
Published on: November 10, 2023
1.7K
09:01Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up
Published on: March 26, 2018
13.9K
相关概念视频
01:22Bone Marrow Sampling and Transplants
270
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
270
02:56Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
01:15Differentiation of Common Myeloid Progenitor Cells
3.2K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.2K
01:23Cells of the Adaptive Immune Response
798
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
798
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K
01:27Disorders of Leukocytes
832
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
832